COVAX

Covax, the Developing World’s Hope against COVID, Has Made It Only Halfway

The Covax initiative, the hope of the countries of the developing South to immunize their populations against COVID-19, only met half of its goals in 2021. And as 2022 begins, and the omicron variant of the virus is spreading fast, the scheme still depends on the decisions of pharmaceutical companies and the goodwill of donor governments.

Vaccine Access Negotiations to Resume as New Variants Spread

A committee that has spent almost a year negotiating the terms of a temporary intellectual property waiver for Covid-19 medicines will reconvene in September after pausing for the European Summer.